特异性细胞免疫的效应细胞是
A.Thl细胞和Th2细胞
B.Thl细胞和ThO细胞
C.Thl细胞和CTL细胞
D.Th2细胞和CTL细胞
E.Th2细胞和Th3细胞
阅读短文,在空白处填入适当的介词。
With One day, Mr. Green told his students to make sentences (1) the words“love, hate” and so on. The kids were all busy (2) the work on their notes.
(3) several minutes many of them handed in their work (4) the teacher.Mr. Green read the notes one (5) one. And most(6)the sentences made by the children were good. There was a big smile(7)his face. Just (8) that time he found a piece of red paper. On it there was such a sentence,“I love my mother better than my father.”“Eim... OK!”said Mr.Green,“but..”He turned over the paper.
He found there were no names (9) that paper. He read the sentence again and again. And slowly the big smile (10) his face was gone. Then he said to the class, “ Whose paper is this?”Tom stood up and said,“It's mine, sir.”
B、结内受侵常见,B症状少见
C、结内受侵常见,B症状常见
D、发病年龄小、病变进展缓慢
E、发病年龄大、病变进展迅速
F、常累及鼻腔、副鼻窦、皮肤和骨髓
以下病毒中,主要与NK/T细胞淋巴瘤相关的是()A、CMV
B、HBV
C、HCV
D、EBV
E、HPV
F、HIV
此患者分期为()A、ⅠB期
B、ⅡA期
C、ⅡB期
D、ⅢA期
E、ⅢB期
F、ⅣB期
此患者的最佳治疗模式为()A、手术
B、放疗
C、化疗
D、放疗+化疗
E、放疗+造血干细胞移植
F、化疗+造血干细胞移植
以下关于NK/T细胞淋巴瘤的描述,不正确的是()A、标准CHOP方案有效率高,缓解期长
B、SMILE方案(DXM+MTX+IFO+L-asp+VP-16)疗效优于CHOP方案
C、吉西他滨为基础的方案,如GEMOX,GDP等有效率高
D、造血干细胞移植不作为常规治疗
E、少数患者发生淋巴瘤相关嗜血细胞综合征(LAHS),表现为高热、全血细胞减少、肝脾肿大等,进展迅速,生存期短
F、早期患者以远处结外器官受侵为治疗失败主要原因,占所有失败的60%~80%
(提示 此患者采用GDP方案化疗2周期后复查MR:软组织增厚较前明显减轻,颈部多发肿大淋巴结较前缩小,鼻咽镜:未见肿瘤征象。疗效评价PR。之后行肿瘤病灶、阳性淋巴结、双侧筛窦、鼻腔、上颌窦、鼻咽、右侧腮腺、舌根、双颈部、双锁骨上下淋巴引流区放射治疗。放疗后复查鼻咽镜及鼻腔MR均显示:双侧鼻腔肿物基本消退,双颈部淋巴结已不具体。放疗后GDP方案化疗2周期。之后患者遵医嘱定期复查。结束治疗1年后,再次出现连续高热3天,最高39摄氏度,行PET/CT:结肠脾曲、降结肠、升结肠管壁多处增厚,以结肠脾曲和降结肠上段为著,伴放射性摄取增高,最大SUV8.3(结肠脾曲)。左侧腹腔不规则软组织影,伴不均匀放射性摄取增高,最大SUV2.8,与左侧肾上腺分界欠清。脾门、腹膜后多发肿大淋巴结,伴放射性摄取增高,最大SUV9.9。鼻咽、口咽软组织未见明确增厚。)此时应采取的治疗模式为()A、手术
B、放疗
C、化疗
D、放疗+化疗
E、放疗+造血干细胞移植
F、化疗+造血干细胞移植